These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 29096683)

  • 21. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
    Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction Between CCL18 and GPR30 Differs from the Interaction Between Estradiol and GPR30.
    Schmidt-Wolf R; Zissel G
    Anticancer Res; 2020 Jun; 40(6):3097-3108. PubMed ID: 32487604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.
    Albanito L; Sisci D; Aquila S; Brunelli E; Vivacqua A; Madeo A; Lappano R; Pandey DP; Picard D; Mauro L; Andò S; Maggiolini M
    Endocrinology; 2008 Aug; 149(8):3799-808. PubMed ID: 18467441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calycosin stimulates proliferation of estrogen receptor-positive human breast cancer cells through downregulation of Bax gene expression and upregulation of Bcl-2 gene expression at low concentrations.
    Chen J; Xiong WB; Xiong Y; Wu YY; Chen XJ; Shao ZJ; Liu LT; Kuang WJ; Tan XS; Zhou LM
    JPEN J Parenter Enteral Nutr; 2011 Nov; 35(6):763-9. PubMed ID: 21799188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.
    Girgert R; Emons G; Gründker C
    Breast Cancer Res Treat; 2012 Jul; 134(1):199-205. PubMed ID: 22290080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of HRG-β1-induced proliferation, migration and invasion of MCF-7 cells by upregulation of GPR30 expression.
    Ruan SQ; Wang SW; Wang ZH; Zhang SZ
    Mol Med Rep; 2012 Jul; 6(1):131-8. PubMed ID: 22576740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
    Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The DHEA metabolite 7β-hydroxy-epiandrosterone exerts anti-estrogenic effects on breast cancer cell lines.
    Sandra N; Ester P; Marie-Agnès P; Robert M; Olivier H
    Steroids; 2012 Apr; 77(5):542-51. PubMed ID: 22342541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo.
    Chen J; Liu L; Hou R; Shao Z; Wu Y; Chen X; Zhou L
    Cancer Lett; 2011 Sep; 308(2):144-51. PubMed ID: 21612861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
    Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
    Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
    Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells.
    Chimento A; Casaburi I; Rosano C; Avena P; De Luca A; Campana C; Martire E; Santolla MF; Maggiolini M; Pezzi V; Sirianni R
    Mol Nutr Food Res; 2014 Mar; 58(3):478-89. PubMed ID: 24019118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The membrane estrogen receptor GPR30 mediates cadmium-induced proliferation of breast cancer cells.
    Yu X; Filardo EJ; Shaikh ZA
    Toxicol Appl Pharmacol; 2010 May; 245(1):83-90. PubMed ID: 20153348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer.
    Mo Z; Liu M; Yang F; Luo H; Li Z; Tu G; Yang G
    Breast Cancer Res; 2013 Nov; 15(6):R114. PubMed ID: 24289103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Action of methyl-, propyl- and butylparaben on GPR30 gene and protein expression, cAMP levels and activation of ERK1/2 and PI3K/Akt signaling pathways in MCF-7 breast cancer cells and MCF-10A non-transformed breast epithelial cells.
    Wróbel AM; Gregoraszczuk EŁ
    Toxicol Lett; 2015 Oct; 238(2):110-6. PubMed ID: 26253279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
    Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPR30-mediated HMGB1 upregulation in CAFs induces autophagy and tamoxifen resistance in ERα-positive breast cancer cells.
    Liu L; Liu S; Luo H; Chen C; Zhang X; He L; Tu G
    Aging (Albany NY); 2021 Jun; 13(12):16178-16197. PubMed ID: 34182538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apple Peel Flavonoid Fraction 4 Suppresses Breast Cancer Cell Growth by Cytostatic and Cytotoxic Mechanisms.
    Loung CY; Fernando W; Rupasinghe HPV; Hoskin DW
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31540221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.